Transplantation of Brain-Derived Neurotrophic Factor-Expressing Mesenchymal Stem Cells Improves Lower Urinary Tract Symptoms in a Rat Model
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
This study aimed to explore the effects of brain-derived neurotrophic factor (BDNF), produced by engineered immortalized mesenchymal stem cells (imMSC), on lower urinary tract symptoms (LUTS) in a rat model with neurogenic bladder (NB). Forty-eight Sprague-Dawley (SD) rats were randomly divided into the following groups: Sham control, LUTS, LUTS+imMSC (treated with immortalized MSC), and LUTS+BDNF-eMSC (treated with BDNF-expressing MSC) groups. LUTS was induced by a crush injury to the major pelvic ganglion (MPG). Bladder function was tested under anesthesia, and bladder tissue strips were collected thereafter for contractility test and western blot analysis. Western blot results showed that the expression of both Angiopoietin 1 (Ang 1) and platelet-derived growth factor (PDGF) increased with MSC injection. The effect of treatment with BDNF-eMSC on LUTS was also evaluated, and the results were found to be better than those with imMSC (P＜0.05). BDNF-eMSC prevented fibrosis in the bladder tissue and significantly reduced caspase-3 levels. In conclusion, high expression of BDNF in vivo resulted in recovery of bladder function and contractility, along with the inhibition of apoptosis in a rat model.
Abstract
This study aimed to explore the effects of brain-derived neurotrophic factor (BDNF), produced by engineered immortalized mesenchymal stem cells (imMSC), on lower urinary tract symptoms (LUTS) in a rat model with neurogenic bladder (NB). Forty-eight Sprague-Dawley (SD) rats were randomly divided into the following groups: Sham control, LUTS, LUTS+imMSC (treated with immortalized MSC), and LUTS+BDNF-eMSC (treated with BDNF-expressing MSC) groups. LUTS was induced by a crush injury to the major pelvic ganglion (MPG). Bladder function was tested under anesthesia, and bladder tissue strips were collected thereafter for contractility test and western blot analysis. Western blot results showed that the expression of both Angiopoietin 1 (Ang 1) and platelet-derived growth factor (PDGF) increased with MSC injection. The effect of treatment with BDNF-eMSC on LUTS was also evaluated, and the results were found to be better than those with imMSC (P＜0.05). BDNF-eMSC prevented fibrosis in the bladder tissue and significantly reduced caspase-3 levels. In conclusion, high expression of BDNF in vivo resulted in recovery of bladder function and contractility, along with the inhibition of apoptosis in a rat model.
참고문헌 (22)
- C. Eveno, "Sexual and urinary dysfunction after proctectomy for rectal cancer", Journal of Visceral Surgery, 147(1), pp.e21~e30 (2010), Elsevier BV[DOI]
- Rizwan Hamid, "Epidemiology and pathophysiology of neurogenic bladder after spinal cord injury", World Journal of Urology, 36(10), pp.1517~1527 (2018), Springer Science and Business Media LLC[DOI]
- Anthony Atala, "Re: Reconstitution of Experimental Neurogenic Bladder Dysfunction Using Skeletal Muscle-Derived Multipotent Stem Cells", Journal of Urology, 185(1), pp.353~353 (2011), Ovid Technologies (Wolters Kluwer Health)[DOI]
- Thomas M. Fandel, "Recruitment of Intracavernously Injected Adipose-Derived Stem Cells to the Major Pelvic Ganglion Improves Erectile Function in a Rat Model of Cavernous Nerve Injury", European Urology, 61(1), pp.201~210 (2012), Elsevier BV[DOI]
- Min Gong, "Immortalized mesenchymal stem cells: an alternative to primary mesenchymal stem cells in neuronal differentiation and neuroregeneration associated studies", Journal of Biomedical Science, 18(1), pp.87~ (2011), Springer Science and Business Media LLC[DOI]
- Seung Hwan Jeon, "Combination Therapy Using Human Adipose-derived Stem Cells on the Cavernous Nerve and Low-energy Shockwaves on the Corpus Cavernosum in a Rat Model of Post-prostatectomy Erectile Dysfunction", Urology, 88, pp.226.e1~226.e9 (2016), Elsevier BV[DOI]
- Seung Jeon, "Engineered Mesenchymal Stem Cells Expressing Stromal Cell-derived Factor-1 Improve Erectile Dysfunction in Streptozotocin-Induced Diabetic Rats", International Journal of Molecular Sciences, 19(12), pp.3730~ (2018), MDPI AG[DOI]
- Matthes SM, "Intravenous transplantation of mesenchymal stromal cells to enhance peripheral nerve regeneration", Biomed Res Int, 2013, pp.573169~ (2013)[DOI]
- Shahin Rafii, "Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration", Nature Medicine, 9(6), pp.702~712 (2003), Springer Science and Business Media LLC[DOI]
- Guan Qun Zhu, "Engineered Stem Cells Improve Neurogenic Bladder by Overexpressing SDF-1 in a Pelvic Nerve Injury Rat Model", Cell Transplantation, 29, pp.096368972090246~ (2020), SAGE Publications[DOI]
- Tong Ming Liu, "Molecular Basis of Immortalization of Human Mesenchymal Stem Cells by Combination of p53 Knockdown and Human Telomerase Reverse Transcriptase Overexpression", Stem Cells and Development, 22(2), pp.268~278 (2013), Mary Ann Liebert Inc[DOI]
- Dong H. Kim, "BDNF Protects Neurons Following Injury by Modulation of Caspase Activity", Neurocritical Care, 3(1), pp.071~076 (2005), Springer Science and Business Media LLC[DOI]
- Krysta R. Nelson, "Prolongation of Relaxation Time in Extraocular Muscles With Brain Derived Neurotrophic Factor in Adult Rabbit", Investigative Opthalmology & Visual Science, 57(13), pp.5834~5842 (2016), Association for Research in Vision and Ophthalmology (ARVO)[DOI]
- Christy L. Willoughby, "Adaptation of Slow Myofibers: The Effect of Sustained BDNF Treatment of Extraocular Muscles in Infant Nonhuman Primates", Investigative Opthalmology & Visual Science, 56(6), pp.3467~3483 (2015), Association for Research in Vision and Ophthalmology (ARVO)[DOI]
- Pelegri NG, "Rat hippocampal neural stem cell modulation using PDGF, VEGF, PDGF", VEGF, and BDNF, 2019, pp.2019, 4978917~
- René Yiou, "Safety of Intracavernous Bone Marrow-Mononuclear Cells for Postradical Prostatectomy Erectile Dysfunction: An Open Dose-Escalation Pilot Study", European Urology, 69(6), pp.988~991 (2016), Elsevier BV[DOI]
- Lisette ‘t Hoen, "Long-term effectiveness and complication rates of bladder augmentation in patients with neurogenic bladder dysfunction: A systematic review", Neurourology and Urodynamics, 36(7), pp.1685~1702 (2017), Wiley[DOI]
- Alan J. Wein, "Re: Long-Term Effectiveness and Complication Rates of Bladder Augmentation in Patients with Neurogenic Bladder Dysfunction: A Systematic Review", Journal of Urology, 201(1), pp.38~39 (2019), Ovid Technologies (Wolters Kluwer Health)[DOI]
- Mostafa A. Rabie, "Angiotensin 1-7 ameliorates 6-hydroxydopamine lesions in hemiparkinsonian rats through activation of MAS receptor", PI3K, BDNF pathway and inhibition of angiotensin II type-1 receptor, pp.NF-κB axis, Biochemical Pharmacology[DOI]
- Omer Kutlu, "Effect of doxazosin on expression of eNOS in rat kidney in the presence of partial bladder outlet obstruction", Journal of Nephrology, 25(5), pp.750~754 (2012), SAGE Publications[DOI]
- 김선옥, "The Expression of AQP1 and eNOS in Menopausal Rat Urinary Bladder", International Neurourology Journal, 14(2), pp.78~85 (2010), 대한배뇨장애요실금학회
- Luiz O. Leiria, "Insulin relaxes bladder via PI3K", AKT, The Journal of Physiology, pp.2013, 591(9)[DOI]